Table 1 Patient characteristics according to treatment group and response to preoperative DCS therapy evaluated by RECIST and histological evaluation criteria

39

39

63.6 (30–78)

67.0 (41–80)

Gender

Male

32

25

Female

7

14

ECOG performance status

≥1

2

0

0

37

39

Borrmann macroscopic type

1

0

1

2

14

10

3

21

16

4

1

10

5

3

2

Differentiation

Diffuse

18

28

Intestinal

21

11

Clinical T stage

cT0

0

0

cT1

0

0

cT2

5

5

cT3

13

16

cT4

21

18

Clinical N stage

cN0

2

0

cN1

2

6

cN2

21

18

cN3

14

15

Clinical stage

0

0

0

I

0

0

II

0

0

III

13

38

IV

26

1

PAN metastasis

(+)

16

0

(−)

23

0

Hepatic metastasis

(+)

9

1

(−)

30

38

RECIST

CR

0

-

PR

29

-

SD

8

-

PD

2

-

Histological evaluation criteria (Grade)

3

3

-

2

19

-

1b

4

-

1a

11

-

0

2

-